Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00170742
Status:
TERMINATED
Last Update Posted:
2008-08-12
First Post:
2005-09-09
Brief Title:
Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Randomized Open Label Controlled Study on the Efficacy and Safety of Octreotide im in Patients With Proliferative Diabetic Retinopathy PDR After Start of Laser Coagulation
Status:
TERMINATED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
trial stopped on Sept 24 2007
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Phase III study comparing monthly octreotide im in comparison to no additional treatment in patients with proliferative diabetic retinopathy after lasercoagulation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None